Delirium severity: how do (or should) we conceptualise and measure it?

Contributed by Zoë Tieges, PhD, Psychology Research Fellow, Geriatric Medicine, Usher Institute, The University of Edinburgh Severity grading of delirium in research and clinical practice may have important value in monitoring clinical course and recovery, in providing prognostic information for risk stratification, in informing treatment, and as endpoints in clinical trials. Fine-grained measures of delirium […]

New Systematic Review of Instruments for Identification of Delirium

Contributed by Benjamin K. I. Helfand, MSc, MD/PhD (candidate), University of Massachusetts Medical School Delirium affects approximately 3 million older Americans annually, accounting for over $164 billion in healthcare expenditures.1 Delirium disproportionately affects our older population (over age 65) with major public health implications. Development of delirium is associated with prolonged hospitalization, cognitive decline, and […]

Delirium and the Power of Storytelling

Contributed by Heidi Lindroth, PhD RN, T32 Postdoctoral Fellow, Indiana University School of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Health Innovation and Implementation Science The COVID-19 pandemic has brought the terror of delirium to the forefront. Featured articles in the New York Times, the Atlantic, and others, have highlighted the enormous […]

Brain Basis of Post-Stroke Delirium

Contributed by Roberta Esteves Vieira de Castro, MD, PhD, Rio de Janeiro State University, D’Or Institute for Research and Education, Latin American Delirium Special Interest Group, Rio de Janeiro, Brazil Delirium is a frequent and malignant aggravation succeeding stroke1,2, with an estimated occurrence ranging from 2 to 66%3,4. It may be a direct consequence of […]